Jennison Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,806
| Closed | -$541K | – | 571 |
|
|
2024
Q2 | $541K | Sell |
7,806
-341,630
| -98% | -$23.7M | ﹤0.01% | 548 |
|
|
2024
Q1 | $28M | Buy |
349,436
+4,321
| +1% | +$346K | 0.02% | 302 |
|
|
2023
Q4 | $37.8M | Sell |
345,115
-19,579
| -5% | -$2.14M | 0.03% | 240 |
|
|
2023
Q3 | $36.8M | Sell |
364,694
-122,910
| -25% | -$12.4M | 0.03% | 224 |
|
|
2023
Q2 | $66.3M | Sell |
487,604
-137,106
| -22% | -$18.6M | 0.05% | 157 |
|
|
2023
Q1 | $64.9M | Buy |
624,710
+5,374
| +0.9% | +$558K | 0.06% | 155 |
|
|
2022
Q4 | $54.9M | Buy |
619,336
+113,530
| +22% | +$10.1M | 0.06% | 174 |
|
|
2022
Q3 | $40.6M | Buy |
505,806
+4,953
| +1% | +$397K | 0.04% | 203 |
|
|
2022
Q2 | $48M | Buy |
500,853
+55,770
| +13% | +$5.34M | 0.05% | 175 |
|
|
2022
Q1 | $66.1M | Buy |
445,083
+133,303
| +43% | +$19.8M | 0.05% | 168 |
|
|
2021
Q4 | $44.2M | Buy |
+311,780
| New | +$44.2M | 0.03% | 246 |
|
|
2020
Q1 | – | Sell |
-3,821
| Closed | -$427K | – | 632 |
|
|
2019
Q4 | $427K | Buy |
+3,821
| New | +$427K | ﹤0.01% | 598 |
|